Kjell-Erik Nordby, Chief Executive Officer
Mr. Nordby has been CEO of Weifa since February 2009, and as of June 2015 CEO of Vistin Pharma. He was Vice President Business Development at Photocure, a Norwegian biotech company. Previous experience includes several years at Alpharma, a leading international generic pharmaceutical company listed on NYSE. He held several top management positions in the company including Head of S&M North Europe Region and as Senior Director API Business Development. Mr. Nordby holds a Master's degree in Pharmacy and Master's degree in Business Administration.
Gunnar Manum, Chief Financial Officer
Mr. Manum joined Weifa as CFO in August 2014, and as of June 2015 as CFO of Vistin Pharma. He previously held the positions as CFO at Aqualis for 7 years, and prior to that he was a senior advisor at Handelsbanken Capital Markets, Corporate Finance, for 8 years. Mr. Manum has a wide ranging experience from several managerial positions within finance and accounting at Stolt Sea Farm and PWC, Australia. He holds a MCom in Finance and Accounting from the University of New South Wales, Sydney.
Valborg Godal Vold, Chief Operating Officer
Ms. Godal Vold joined Weifa in October 2012 as Vice President B2B Sales & Marketing. From June 2015 as VP Sales & Marketing and from October 2017 as Chief Operating Officer, Vistin Pharma. She is an experienced executive manager within the biotechnology and pharmaceutical industry. Ms. Godal Vold holds a BA in Biomedical Laboratory Science (BLS) and an Executive Master in Business & Administration from BI Norwegian Business School /ESCP-EAP Paris.
Vegard Heggem, Vice President Operations
Mr. Heggem joined Weifa in May 2010 as Director of Synthesis Production and Site Manager of the Fikkjebakke plant, and continued in the same position in Vistin Pharma from June 2015. Mr. Heggem has extensive experience from different managerial positions within operations, engineering and investment projects. Mr. Heggem holds a Master’s degree in Chemical Engineering from The Norwegian University of Science and Technology (NTNU) in Trondheim.
Hilde Merete Hagen, Vice President Quality & Regulatory Affairs
Ms Hagen joined Weifa/Vistin Pharma in March 2015 and has held the position as VP Quality & Regulatory affairs since then, with a short break of 4 months working on a consultancy basis on specific projects. She came from the position as VP Quality & Regulatory Affairs in Pronova BioPharma/BASF, where she has held different managerial positions within QC, QA, R&D and project management during her 19 years with the company. Ms Hagen holds a Master of Science degree from the University of Oslo and a Master of Management degree from BI Norwegian Business School.